GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Clinical trial NCT04083599 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04083599
Sponsor: Genmab
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Solid Tumor Non-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Melanoma Head and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic Ductal Adenocarcinoma (PDAC)

Start date: 2019-09-17
Primary completion: 2025-12-30
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.